ArticleMolecular pain2016

Rho/ROCK acts downstream of lysophosphatidic acid receptor 1 in modulating P2X3 receptor-mediated bone cancer pain in rats.

Jing-Xiang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.